Publications

2017 | ARTICLE


Bristol-Myers Squibb and Mosaic Laboratories (Referenced in Methods)

Sharma P, Retz M, Siefker-Radtke A, Baron A, Necchi A, Bedke J, et al.

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2017 Mar;18(3):312-322.